Together, these results suggest that in certain cancer cells, REV-ERBα has lost its function in repression of clock and metabolic genes, and instead, it plays a previously unrecognized role in stimulation of multiple tumorigenic programs including PI3K-Akt and MAPK signaling pathways, cell cycle, and lipid metabolism. Here, AKT1 is linked to cancer.